FDA approves Bayer's Ultravist (iopromide) Injection for Contrast-enhanced Mammography
Contrast-enhanced mammography (CEM) is an emerging modality combining digital mammography with the administration of a contrast agent
Source: itnonline.com
Page 5 - Breast Density News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breast Density. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breast Density Today - Breaking & Trending Today
FDA approves Bayer's Ultravist® (iopromide) injection for contrast-enhanced mammography | Business
WHIPPANY, N.J.--(BUSINESS WIRE)--Jun 23, 2023--
Source: maryvilleforum.com
FDA approves Bayer's Ultravist® (iopromide) injection for contrast-enhanced mammography | Region
WHIPPANY, N.J.--(BUSINESS WIRE)--Jun 23, 2023--
Source: eagletribune.com
KPIX CBS Evening News With Norah ODonnell June 4, 2024 22:43:00
Than current methods. >> reporter: it's cutting-edge research. artificial intelligence is significantly better at predicting a patient's cancer risk, according to a new study out today. >> the role of ai in protecting breast cancer risk is definitely in our future. >> reporter: dr. polly niravath is a oncologist with houston methodist. >> assesses a person's risk, the ai can do it probably a lot cheaper, and a lot faster, as well. >> reporter: front of my current clinical models use a patient's age, family history, and breast density to determine risk fear of artificial intelligence is able to...
Source: archive.org
International workshop on breast cancer research headed to Kona : Big Island Now
In an ongoing effort to understand and treat the illness, more than 100 physicians, researchers, allied health professionals and advocates will descend on Kailua-Kona to attend the 10th International Breast Density & Cancer Risk Assessment Workshop next month.
Source: bigislandnow.com